← Back to all stories
Popular GLP-1 Medications Linked to Significant Drop in Asthma and COPD Flare-Ups
Photo: Lucas Vasques / Unsplash
A large-scale, real-world study has found that semaglutide is associated with nearly 40% fewer asthma attacks and a 20% reduction in COPD flare-ups. Researchers believe these widely-used medications may offer powerful new respiratory benefits alongside their established roles in treating diabetes and obesity.
A large-scale, real-world study has found that semaglutide is associated with nearly 40% fewer asthma attacks and a 20% reduction in COPD flare-ups. Researchers believe these widely-used medications may offer powerful new respiratory benefits alongside their established roles in treating diabetes and obesity.